Abstract Protein kinase C (PKC) inhibitors are useful tools for studying PKC-dependent regulation of ion channels. For this purpose, high PKC specificity is a basic requirement excluding any direct interaction between the PKC inhibitor and the ion channel. In the present study, the effects of two frequently applied PKC inhibitors, chelerythine and bisindolylmaleimide I, were studied on the rapid and slow components of the delayed rectifier K + current (I Kr and I Ks ) in canine ventricular cardiomyocytes and on the human ether-à-go-go-related gene (hERG) channels expressed in human embryonic kidney (HEK) cells. The whole cell version of the patch clamp technique was used in all experiments. Chelerythrine and bisindolylmaleimide I (both 1 μM) suppressed I Kr in canine ventricular cells. This inhibition developed rapidly, suggesting a direct drugchannel interaction. In HEK cells heterologously expressing hERG channels, chelerythrine and bisindolylmaleimide I blocked hERG current in a concentration-dependent manner, having EC 50 values of 0.11±0.01 and 0.76±0.04 μM, respectively. Both chelerythrine and bisindolylmaleimide I strongly modified gating kinetics of hERG-voltage dependence of activation was shifted towards more negative voltages and activation was accelerated. Deactivation was slowed by bisindolylmaleimide I but not by chelerythrine. I Ks was not significantly altered by bisindolylmaleimide I and chelerythrine. No significant effect of 0.1 μM bisindolylmaleimide I or 0.1 μM PMA (PKC activator) was observed on I Kr arguing against significant contribution of PKC to regulation of I Kr . It is concluded that neither chelerythrine nor bisindolylmaleimide I is suitable for selective PKC blockade due to their direct blocking actions on the hERG channel.
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Introduction
Delayed rectifier K + currents play a pivotal role in repolarization of the cardiac action potential. In the ventricular myocardium of most mammalian species, including dog and human, delayed rectifier K + current is composed of two independent components called I Kr and I Ks (Gintant 1996; Li et al. 1996) . Both components are known to be under the control of the cAMP/PKA pathway, while the role of protein kinase C (PKC) in regulation of I Kr and I Ks is controversial, and therefore, poorly understood in spite of the extensive investigations of the field (Tohse et al. 1990; Kathöfer et al. 2003; Xiao et al. 2003; Thomas et al. 2003; Thomas et al. 2004a; Toda et al. 2007; Matavel and Lopes 2009 ). An appropriate approach of this problem might be the application of selective PKC inhibitors, provided that these agents fail to interact directly with the ion channels mediating delayed rectifier K + currents. These conditions, however, have never been controlled, except for an early study demonstrating that I Kr was directly blocked by bisindolylmaleimide I in guinea pig ventricular cells (Thomas et al. 2004b) . The aim of the present work was to study the effects of two frequently used PKC inhibitors, chelerythrine and bisindolylmaleimide I, on the rapid and slow components of the delayed rectifier K + current (I Kr and I Ks ) in ventricular cardiomyocytes of the dog, a species having action potential characteristics and properties of the underlying transmembrane ion currents most resembling the human (Szentadrássy et al. 2005; Szabó et al. 2005) . Direct effects of the compounds were tested in an expression system containing human ether-à-go-go-related gene (hERG) channels not coupled to signal transduction pathways. It was found that both chelerythrine and bisindolylmaleimide I caused direct blockade of I Kr -but not I Ks -indicating that these drugs are not suitable to study the contribution of the PKC system to physiological regulation of I Kr .
Materials and methods

Experiments with isolated canine cardiomyocytes
Single canine ventricular myocytes were obtained from hearts of adult beagle dogs using the segment perfusion technique (Magyar et al. 2000) . The animals (10-14 kg) were anesthetized with i.v. injection of 10 mg/kg ketamine hydrochloride (Calypsol, Richter Gedeon, Hungary)+1 mg/kg xylazine hydrochloride (Sedaxylan, Eurovet Animal Health BV, The Netherlands). After opening the chest, the heart was rapidly removed and the left anterior descending coronary artery was perfused using a Langendorff apparatus. Ca 2+ -free JMM solution (Minimum Essential Medium Eagle, Joklik Modification, Sigma), supplemented with taurine (2.5 g/l), pyruvic acid (175 mg/l), ribose (750 mg/l), allopurinol (13.5 mg/l), and NaH 2 PO 4 (200 mg/l), was used during the initial 5 min of perfusion to remove Ca 2+ and blood from the tissue. After the addition of NaHCO 3 (1.3 g/l), the pH of this perfusate was adjusted to 6.9 by equilibrating the solution with a mixture of 95% O 2 and 5% CO 2 . Cell dispersion was performed for 30 min in the same solution containing also collagenase (660 mg/l, Worthington CLS-II), bovine albumin (2 g/l), and CaCl 2 (50 μM). During the isolation procedure, the solutions were gassed with carbogen and the temperature was maintained at 37°C. The cells were rod-shaped and showed clear striation when the external calcium was restored.
I Kr and I Ks were recorded at 37°C from Ca 2+ -tolerant canine ventricular cells superfused with Tyrode's solution containing (in millimolar) NaCl, 140; KCl, 5.4; CaCl 2 , 2.5; MgCl 2 , 1.2; HEPES, 5; and glucose, 10 at pH 7.4. This superfusate was supplemented with 5 μM nifedipine plus 1 μM E-4031 when measuring I Ks or 5 μM nifedipine plus 1 μM HMR-1556 in case of recording I Kr in order to eliminate L-type Ca 2+ current, I Kr , or I Ks , respectively. Suction pipettes, fabricated from borosilicate glass, had tip resistances of 1.5-2 MΩ after filling with pipette solution composed of (in millimolar) K aspartate, 100; KCl, 45; MgCl 2 , 1; HEPES, 5; EGTA, 10; and K-ATP, 3. The pH of this solution was adjusted to 7.2 with KOH. Membrane currents were recorded with an Axopatch 200B amplifier (Axon Instruments) using the whole-cell configuration of the patch clamp technique. After establishing a high (1-10 GΩ) resistance seal by gentle suction, the cell membrane beneath the tip of the electrode was disrupted by further suctioning or by applying 1.5-V electrical pulses for 1 ms. Ion currents were normalized to cell capacitance, determined in each cell using short hyperpolarizing pulses from −10 to −20 mV. The series resistance was typically 4-8 MΩ before compensation (usually 50-80%) prior to the measurement. Experiments were discarded when the amplitude of I Kr or I Ks was unstable within the initial 5 min of the experiment, or the series resistance was high or increased during the measurement. Outputs from the clamp amplifier were digitized at 20 kHz using an A/D converter (Digidata 1200, Axon Instruments) under software control (pClamp 6.0, Axon Instruments).
hERG current measurements in transfected human embryonic kidney cells
The hERG channels were expressed in a stable manner in a human embryonic kidney (HEK)-293 cell line. Cells were grown in Dulbecco's minimum essential medium-high glucose supplemented with 10% FBS, 2 mM L-glutamine, 0.11 mg/ml Na pyruvate, 100 U/ml penicillin-G, 0.1 mg/ml streptomycin (Invitrogen), 5 ml non-essential amino acid (Sigma-Aldrich) at 37°C in a 5% CO 2 and 95% airhumidified atmosphere.
Whole-cell currents were measured in voltage-clamped cells using Axopatch 200A amplifiers connected to a personal computer using an Axon Digidata 1200 data acquisition hardware (Molecular Devices Inc., Sunnyvale, CA). A series resistance compensation of up to 70% was used to minimize voltage errors and achieve good voltage-clamp conditions. Pipettes were pulled from GC 150 F-15 borosilicate glass capillaries in five stages and fire-polished, resulting in electrodes having 4-6 MΩ of resistance in the bath. The bath solution contained (in millimolar) choline Cl, 140; KCl, 5; MgCl 2 , 2; CaCl 2 , 2; CdCl 2 , 0.1; glucose, 20; and HEPES, 10 at pH=7.35. The internal solution consisted of (in millimolar) KCl, 140; EGTA, 10; MgCl 2 , 2; and HEPES, 10 at pH=7.3. Superfusion with different test solutions was achieved using a continuous perfusion system based on gravity flow. For data acquisition and analysis, the pClamp software package was used. Currents were low-pass-filtered using the built-in analog four-pole Bessel filters of the amplifiers and sampled at 2 kHz. Before analysis, whole-cell current traces were corrected for ohmic leakage and digitally filtered (three-point boxcar smoothing).
All values presented are arithmetic means ± standard error of the mean (SEM). Statistical significance of differences was evaluated using one-way ANOVA followed by the Student's t test for paired or unpaired data, as pertinent. Differences were considered significant when the P value was less than 0.05. The principles of laboratory animal care (NIH publication no. 85-23, revised 1985) and current version of the Hungarian Law on the Protection of Animals were strictly followed throughout the experiments.
Results
Effects of chelerythrine and bisindolylmaleimide I on I Kr in canine ventricular myocytes I Kr was activated by 250-ms depolarizing pulses to +10 mV applied at a rate of 0.05 Hz. I Kr was characterized as tail current amplitudes determined as the difference of the peak current and the pedestal value observed following repolarization to the holding potential of −40 mV in the presence of 5 μM nifedipine plus 1 μM HMR-1556. These I Kr current tails were fully eliminated by 1 μM E-4031 indicating that the current can be considered as pure I Kr mediated by hERG channels.
Exposure of myocytes to the PKC inhibitor bisindolylmaleimide I (1 μM) decreased I Kr tail amplitude from 0.36±0.05 to 0.11±0.04 pA/pF (P<0.05, n=5, Fig. 1a-c) . Similar results were obtained with another PKC inhibitor chelerythrine (1 μM), where I Kr tail current decreased from 0.39±0.04 to 0.05±0.02 pA/pF (P<0.05, n=4, Fig. 1d-f) . I Kr was fully eliminated by 10 μM chelerythrine (n=3, not shown). In both cases, the blockade of I Kr developed rapidly; the maximal effect was typically achieved within a few minutes (Fig. 1b, e) .
Effects of chelerythrine and bisindolylmaleimide I on hERG current in transfected HEK-293 cells
The hERG current was activated by depolarization to +30 mV for 3 s, which was followed by a repolarization to −40 mV allowing for relaxation of the current resulting tail current. The amplitude of the tail current was considered as an indicator of hERG current density. In these experiments, the holding potential was set to −80 mV, pulses were delivered every 30 s. Both PKC inhibitors, bisindolylmaleimide I and chelerythrine, caused a concentration-dependent suppression of the hERG current (Fig. 2) . This blockade was readily reversible in the case of bisindolylmaleimide I (Fig. 2a) but only partially in the case of chelerythrine. Fitting data to the Hill equation, the estimated EC 50 values were 0.76±0.04 and 0.11±0.01 μM for bisindolylmaleimide I and chelerythrine, respectively, with the corresponding Hill coefficient of 1.21±0.07 and 1.52±0.18 (n=4 for each drug).
Both bisindolylmaleimide I and chelerythrine modified the gating kinetics of the hERG current (Fig. 3) . Voltage dependence of steady-state activation was obtained by measuring tail current amplitudes at −40 mV following test pulses clamped to various voltages indicated in abscissa. (Fig. 3a, d ).
Time dependence of activation of the hERG current was determined using the tail envelope test. Tail currents were recorded at −40 mV following test depolarizations (to +30 mV) having increasing durations as shown in the abscissa. In the presence of bisindolylmaleimide I and chelerythrine, the longest test pulse was 0.8 s since activation was fully saturated by this time. Each tail current was normalized to that of the highest amplitude. Time constants for activation were determined by monoexponential fitting. Activation was accelerated by both compounds. Accordingly, the time constant of activation was reduced from 301±57 to 143±22 ms and from 247±19 to 146± 5 ms by 1 μM bisindolylmaleimide I and 0.1 μM chelerythrine, respectively (P<0.05, n=4 for each drug; Fig. 3b, e) .
Time constant of deactivation was measured at −40 mV following a 3-s-long depolarization to +30 mV. Deactivation was determined as a sum of two exponential components characterized by fast and slow time constants (τ 1 , τ 2 ) and the corresponding amplitudes (A 1 , A 2 ). Bisindolylmaleimide I (1 μM) significantly increased the fast and slow time constants of deactivation, while 0.1 μM chelerythrine left these time constants unaffected as indicated by Fig. 3c, f . See also the insets presented in Fig. 2a, c. Possible role of PKC in the regulation of I Kr in canine ventricular cells
Although the direct blockade of hERG current by chelerythrine and bisindolylmaleimide I was demonstrated above, the effect of PKC inhibition had to be also examined. In these experiments, a lower (0.1 μM) concentration of bisindolylmaleimide I, blocking PKC effectively with relatively small direct blocking action on I Kr , was used. The effect of 0.1 μM bisindolylmaleimide I was tested using both low cytosolic Ca 2+ concentration (buffered by 10 mM EGTA) and high cytosolic Ca 2+ level, where [Ca 2+ ] i was set to 500 nM using the Fabiato program (Fabiato and Fabiato 1979) . This was designed to distinguish between possible effects on the calcium-sensitive conventional and calcium-insensitive novel PKC isoforms (Mellor and Parker 1998) . As shown in Fig. 4a-b , inhibition of PKC by 0.1 μM bisindolylmaleimide I failed to alter the I Kr tail amplitude significantly, which was independent of the actual level of Ca i 2+ . Similarly, I Kr was not modified significantly by activation of PKC by 0.1 μM PMA in the presence of 0.5 μM cytosolic Ca 2+ (Fig. 4c) . These results strongly suggest that PKC inhibition itself has little effect on the amplitude of I Kr in canine ventricular cells.
Effects of chelerythrine and bisindolylmaleimide I on I Ks
For the sake of comparison, effects of the two PKC inhibitors were studied also on I Ks . I Ks was activated in the presence of 5 μM nifedipine plus 1 μM E-4031 by 3-slong depolarizing pulses to +30 mV delivered at a rate of 0.1 Hz from the holding potential of −40 mV. Tail currents, obtained after repolarization, were used to characterize I Ks . The current was fully eliminated by 1 μM HMR-1556, indicating that it was pure I Ks .
Exposure of myocytes to bisindolylmaleimide I (1 μM) or chelererythrine (1 μM) caused small, statistically not significant, increases in I Ks tail amplitudes; I Ks was increased from 1.28±0.35 to 1.55±0.41 pA/pF (P=0.26, ) and from 1.26±0.23 to 1.41±0.32 pA/pF (P=0.58, n=6), respectively (Fig. 5) .
Discussion
In the present work, the effects of two frequently used PKC inhibitors, chelerythine and bisindolylmaleimide I, were studied on the rapid and slow components of the delayed rectifier K + current (I Kr and I Ks ) in canine ventricular cardiomyocytes. I Kr -but not I Ks -was strongly suppressed by both agents. Since the inhibitory effects of chelerythine and bisindolylmaleimide I were observed also in pure hERG channels expressed without co-expression of the members of the PKC system in HEK cells, one may conclude that these drugs block I Kr directly, i.e., independently of their PKC-inhibiting potencies. This is further supported by the findings that (1) the effects of chelerythine and bisindolylmaleimide I developed rapidly and (2) manipulation of the PKC system by PMA and low concentration of bisindolylmaleimide I failed to alter I Kr significantly. Although bisindolylmaleimide I has been previously reported to block hERG current directly (Thomas et al. 2004b) , we are first to report a direct inhibition of hERG current and canine I Kr by another PKC inhibitor, chelerythrine.
In addition to their blocking action, chelerythine and bisindolylmaleimide I caused marked changes in gating kinetics of hERG current, including a negative shift in voltage dependence of activation, acceleration of activation, and slowing of deactivation (this latter was observed only with bisindolylmaleimide I). Since these kinetic changes are incompatible with current inhibition (they are actually congruent with enhancement of the current), the blocking effect of bisindolylmaleimide I and chelerythrine is likely based on a cork-in-the-bottle mechanism of open channel block rather than being related to the observed alterations in gating kinetics.
Direct inhibition of hERG channels is not an exceptional side effect of PKC inhibitors. The hERG-inhibitor effect of bisindolylmaleimide I has been previously described by Thomas et al. (2004b) presenting results very congruent with ours. The EC 50 value obtained in the HEK cells was 0.76 μM in ours, while 1 μM in their experiments. Bisindolylmaleimide I (1 μM) caused a 69.2% inhibition in the native I Kr of guinea pigs (Thomas et al. 2004b ) and a 69.4% blockade of canine I Kr (present study). An interesting difference between the results of the two studies can be observed in the kinetic properties of I Kr blockade. We found a marked leftward shift of −12.2 mV in the voltage dependence of I Kr activation in the presence of bisindolylmaleimide I, while only a small, statistically not significant change of −2.9 mV was seen by Thomas et al. (2004b) . The reason for this discrepancy is not clear at present; it might partly be caused by an improvement of voltage control due to reduction of hERG current amplitudes. However, a −20.3-mV leftward shift in steady-state inactivation was reported by Thomas et al. (2004b) , which may in fact contribute to the bisindolylmaleimide I-induced I Kr blockade.
In addition to I Kr blockade, both chelerythrine and bisindolylmaleimide I were shown to block voltageactivated K + and Ca 2+ channels in rat ventricular cells, which, in effect-similarly to our results-proved to be independent of PKC inhibition (Voutilainen-Myllyla et al. . Acetylcholine-activated K + current was also blocked by chelerythrine and bisindolylmaleimide I in murine atrial myocytes (Cho et al. 2001) . Furthermore, bisindolylmaleimide I inhibited voltage-dependent K + channels in arterial smooth muscle cells of rats and mice (Kim et al. 2004; Park et al. 2005) , while another PKC inhibitor, staurosporine, enhanced the activity of cardiac Na + /Ca 2+ exchanger in a PKC-independent manner (Kang 2008) . It would be interesting to know which part(s) of these molecules is (are) responsible for their ionotropic actions since proper modification of these groups might result to PKC inhibitors with less intensive interactions with ion channels, improving thus their specificity to PKC.
Although the general conclusion of this work is that neither chelerythine nor bisindolylmaleimide I is really suitable for studying the contribution of PKC in regulation of cardiacdelayed rectifier K + channels, some cautious remarks on this point can be made. The low concentration (0.1 μM) of bisindolylmaleimide I, which is known to block PKC effectively, while was shown in Fig. 2b to cause approximately 10% inhibition of hERG current, failed to decrease I Kr tail amplitudes in intact canine ventricular cells (as shown in Fig. 4a, b) . In contrast, there was a mild tendency of current increase during the 30-min period of superfusion. Furthermore, activation of PKC by PMA tended to slightly decrease I Kr (Fig. 4c ). Since the above-mentioned changes were not significant statistically, they cannot be considered conclusive. The fact, however, that the 10% inhibition was not observed on canine I Kr in the presence of 0.1 μM bisindolylmaleimide I suggests that PKC might moderately suppress I Kr under control conditions, thus, allowing the current to increase slightly upon inhibition of PKC. This is congruent with previous results on hERG channels expressed in Xenopus oocytes, where activation of the conventional PKC isoenzymes with thymelatoxin was shown to decrease I Kr .
Similar to results obtained with I Kr , a moderate, but again statistically not significant, enhancement of I Ks was observed after superfusion with 1 μM chelerythrine or bisindolylmaleimide I (Fig. 5) . Regarding the role of PKC in controlling I Ks , the published observations are quite controversial and show strong interspecies differences. For instance, the activation of PKC was shown to enhance I Ks in native cardiac cells of the guinea pig (Tohse et al. 1990; Heath and Terrar 2000; Toda et al. 2007 ) and in oocytes expressing human I Ks channel proteins (Xiao et al. 2003; Kathöfer et al. 2003; Matavel and Lopes 2009) . In contrast, I Ks was suppressed by PKC activation when the oocytes were transfected with murine or rat I Ks channels (Honoré et al. 1991 , Busch et al. 1992 . Our results suggest that the PKC-dependent modulation of I Ks in dogs may be restricted to a moderate tonic inhibition, which can be suspended by blockade of the enzyme. It is interesting to note that I Ks was reduced by 20% after superfusion with phenylephrine in canine myocytes (Robinson et al. 2000) . This is in line with our findings, i.e., with the slight increase of I Ks observed in the presence of PKC inhibitors (even if the difference failed to reach the level of statistical significance).
